Robotic Gait Training + Physical Therapy for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different approaches to improve walking skills in children with cerebral palsy. It compares four therapies: one using a robotic device called Lokomat, one focusing on gait-focused physical therapy exercises, one combining both methods, and a regular maintenance therapy. The goal is to determine which method best enhances walking abilities, balance, fitness, and overall quality of life. Children with cerebral palsy who can walk, follow instructions, and participate in therapy sessions may be good candidates for this study.
As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research that could significantly improve therapeutic approaches for children with cerebral palsy.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, regular physical therapy and other gross motor mobility therapies must be discontinued during the trial, except for home programs like stretching and light exercise.
What prior data suggests that robotic gait training and physical therapy are safe for children with cerebral palsy?
Research has shown that both the Lokomat and gait-focused physical therapy are generally safe for children with cerebral palsy. The Lokomat, a robotic device that aids in walking practice, has been found safe for children to use, allowing them to practice walking skills without reported safety issues.
Gait-focused physical therapy is also supported by research as safe, with no reports of problems like pain or tiredness during sessions. This therapy improves walking by focusing on exercises that enhance balance and coordination.
When used together, the Lokomat and physical therapy remain safe and well-tolerated by children, according to multiple studies. Promising evidence suggests these treatments can improve walking ability without causing harm.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for cerebral palsy because they offer innovative approaches to improving mobility. The Lokomat (LOK) robotic gait training stands out due to its use of a robotic exoskeleton that provides a goal-based method to enhance walking skills, encouraging dual-tasking and improving posture through motor imagery practice. Meanwhile, the gait-focused physical therapy (fPT) emphasizes motor learning by allowing children to practice motor skills through diverse activities without relying on techniques that change body structure. These approaches are different from traditional physical therapies, which may not incorporate advanced robotic technology or a strong focus on motor learning principles.
What evidence suggests that this trial's treatments could be effective for cerebral palsy?
Research has shown that Lokomat therapy, a treatment in this trial, can improve walking skills in children with cerebral palsy. Studies have found it to be as effective as traditional physical therapy, though not necessarily superior. Gait-focused physical therapy, another treatment arm in this trial, aims to increase walking speed, as reviews of multiple studies have suggested. Both Lokomat therapy and gait-focused physical therapy aim to enhance the walking abilities of children with cerebral palsy. While each method works well independently, participants in this trial may receive a combination of both, potentially offering additional benefits by combining their strengths.12678
Who Is on the Research Team?
Lesley Wiart, PhD
Principal Investigator
University of Alberta
Virginia Wright, PhD
Principal Investigator
Holland Bloorview Kids Rehabilitation Hospital
Are You a Good Fit for This Trial?
This trial is for children and youth aged 5-18 with Cerebral Palsy, specifically those who can follow instructions for a walking test and participate in active physical therapy. They should be able to communicate discomfort and have certain levels of hip and knee flexibility. Participants must commit to multiple sessions over several weeks but cannot receive other mobility therapies during the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either LOK, fPT, or LOK+fPT interventions, consisting of two 50-minute sessions per week over 8 to 10 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3 months post-intervention
Qualitative Interviews
Interviews with children and parents to gather insights on experiences and outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Gait focused physical therapy
- Lokomat
- Regular Maintenance Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Northeastern University
Collaborator
Holland Bloorview Kids Rehabilitation Hospital
Collaborator
Shirley Ryan AbilityLab
Collaborator